Risk factors for clinically significant diffuse parenchymal lung abnormalities persisting after severe COVID-19 pneumonia.

Sahajal Dhooria,Siddhant Arora,Shivani Chaudhary,Inderpaul Singh Sehgal,Nidhi Prabhakar, Nasim Mohammad,Riya Sharma,Prabir Das,Yashwant Kumar,Mandeep Garg,Goverdhan Dutt Puri,Ashish Bhalla,Valliappan Muthu,Kuruswamy Thurai Prasad,Ritesh Agarwal,Ashutosh Nath Aggarwal

The Indian journal of medical research（2023）

引用 0|浏览7

暂无评分

摘要

Longer hospital stay was observed to be the only independent predictor of CS-DPLA six months after severe COVID-19. Serum TGF-β should be evaluated further as a biomarker.

查看译文

关键词

Biomarker, interstitial lung abnormalities, interstitial lung disease, long COVID-2019, lung fibrosis, sequelae

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要